Cryo-Cell International Inc.

Egan-jones proxy services recommends that cryo-cell stockholders vote for all management nominees “We Believe That Voting the Management Ballot is in the Best Interest of the Company and its Shareholders.”

Company Receives Multiple Offers from Prospective Buyers

Company Achieves Historical Corporate Milestone with Tenth Consecutive Quarter of Profitability Combined with Year-over-Year Revenue Growth and Double-Digit Unit Growth

Cryo-Cell International, Inc. one of the world’s largest and most established family cord blood banks and global industry leader in innovative stem cell solutions.

Company Reported To Have Highest Earnings Yield in Health Care Services Industry

Company Introduces New Services Designed to Provide Expanded Options to Potentially Extend Future Family Healthcare Protection

Strategic Move to OTCQX U.S. Premier Distinguishes Company and Potentially Positions Cryo-Cell for Future Listing on a National Stock Exchange

Company’s Revolutionary Menstrual Stem Cell Technology May Potentially Transform the Stem Cell Industry

Company Reports Ninth Consecutive Quarter of Profitability, Revenue Growth and Double-Digit Unit Growth.

Cryo-Cell International Recognized as Undervalued Among Companies in the Life Sciences Tools & Services Industry